Cargando…

Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase

BACKGROUND: The sphingolipids galactosylceramide (GalCer) and sulfatide are major myelin components and are thought to play important roles in myelin function. The importance of GalCer and sulfatide has been validated using UDP-galactose:ceramide galactosyltransferase-deficient (Cgt(-/-)) mice, whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Meixner, Marion, Jungnickel, Julia, Grothe, Claudia, Gieselmann, Volkmar, Eckhardt, Matthias
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053264/
https://www.ncbi.nlm.nih.gov/pubmed/21366909
http://dx.doi.org/10.1186/1471-2202-12-22
_version_ 1782199721615425536
author Meixner, Marion
Jungnickel, Julia
Grothe, Claudia
Gieselmann, Volkmar
Eckhardt, Matthias
author_facet Meixner, Marion
Jungnickel, Julia
Grothe, Claudia
Gieselmann, Volkmar
Eckhardt, Matthias
author_sort Meixner, Marion
collection PubMed
description BACKGROUND: The sphingolipids galactosylceramide (GalCer) and sulfatide are major myelin components and are thought to play important roles in myelin function. The importance of GalCer and sulfatide has been validated using UDP-galactose:ceramide galactosyltransferase-deficient (Cgt(-/-)) mice, which are impaired in myelin maintenance. These mice, however, are still able to form compact myelin. Loss of GalCer and sulfatide in these mice is accompanied by up-regulation of 2-hydroxylated fatty acid containing (HFA)-glucosylceramide in myelin. This was interpreted as a partial compensation of the loss of HFA-GalCer, which may prevent a more severe myelin phenotype. In order to test this hypothesis, we have generated Cgt(-/- )mice with an additional deletion of the fatty acid 2-hydroxylase (Fa2h) gene. RESULTS: Fa2h(-/-)/Cgt(-/- )double-deficient mice lack sulfatide, GalCer, and in addition HFA-GlcCer and sphingomyelin. Interestingly, compared to Cgt(-/- )mice the amount of GlcCer in CNS myelin was strongly reduced in Fa2h(-/-)/Cgt(-/- )mice by more than 80%. This was accompanied by a significant increase in sphingomyelin, which was the predominant sphingolipid in Fa2h(-/-)/Cgt(-/- )mice. Despite these significant changes in myelin sphingolipids, compact myelin was formed in Fa2h(-/-)/Cgt(-/- )mice, and g-ratios of myelinated axons in the spinal cord of 4-week-old Fa2h(-/-)/Cgt(-/- )mice did not differ significantly from that of Cgt(-/- )mice, and there was no obvious phenotypic difference between Fa2h(-/-)/Cgt(-/- )and Cgt(-/- )mice CONCLUSIONS: These data show that compact myelin can be formed with non-hydroxylated sphingomyelin as the predominant sphingolipid and suggest that the presence of HFA-GlcCer and HFA-sphingomyelin in Cgt(-/- )mice does not functionally compensate the loss of HFA-GalCer.
format Text
id pubmed-3053264
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30532642011-03-11 Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase Meixner, Marion Jungnickel, Julia Grothe, Claudia Gieselmann, Volkmar Eckhardt, Matthias BMC Neurosci Research Article BACKGROUND: The sphingolipids galactosylceramide (GalCer) and sulfatide are major myelin components and are thought to play important roles in myelin function. The importance of GalCer and sulfatide has been validated using UDP-galactose:ceramide galactosyltransferase-deficient (Cgt(-/-)) mice, which are impaired in myelin maintenance. These mice, however, are still able to form compact myelin. Loss of GalCer and sulfatide in these mice is accompanied by up-regulation of 2-hydroxylated fatty acid containing (HFA)-glucosylceramide in myelin. This was interpreted as a partial compensation of the loss of HFA-GalCer, which may prevent a more severe myelin phenotype. In order to test this hypothesis, we have generated Cgt(-/- )mice with an additional deletion of the fatty acid 2-hydroxylase (Fa2h) gene. RESULTS: Fa2h(-/-)/Cgt(-/- )double-deficient mice lack sulfatide, GalCer, and in addition HFA-GlcCer and sphingomyelin. Interestingly, compared to Cgt(-/- )mice the amount of GlcCer in CNS myelin was strongly reduced in Fa2h(-/-)/Cgt(-/- )mice by more than 80%. This was accompanied by a significant increase in sphingomyelin, which was the predominant sphingolipid in Fa2h(-/-)/Cgt(-/- )mice. Despite these significant changes in myelin sphingolipids, compact myelin was formed in Fa2h(-/-)/Cgt(-/- )mice, and g-ratios of myelinated axons in the spinal cord of 4-week-old Fa2h(-/-)/Cgt(-/- )mice did not differ significantly from that of Cgt(-/- )mice, and there was no obvious phenotypic difference between Fa2h(-/-)/Cgt(-/- )and Cgt(-/- )mice CONCLUSIONS: These data show that compact myelin can be formed with non-hydroxylated sphingomyelin as the predominant sphingolipid and suggest that the presence of HFA-GlcCer and HFA-sphingomyelin in Cgt(-/- )mice does not functionally compensate the loss of HFA-GalCer. BioMed Central 2011-03-02 /pmc/articles/PMC3053264/ /pubmed/21366909 http://dx.doi.org/10.1186/1471-2202-12-22 Text en Copyright ©2011 Meixner et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Meixner, Marion
Jungnickel, Julia
Grothe, Claudia
Gieselmann, Volkmar
Eckhardt, Matthias
Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase
title Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase
title_full Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase
title_fullStr Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase
title_full_unstemmed Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase
title_short Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase
title_sort myelination in the absence of udp-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053264/
https://www.ncbi.nlm.nih.gov/pubmed/21366909
http://dx.doi.org/10.1186/1471-2202-12-22
work_keys_str_mv AT meixnermarion myelinationintheabsenceofudpgalactoseceramidegalactosyltransferaseandfattyacid2hydroxylase
AT jungnickeljulia myelinationintheabsenceofudpgalactoseceramidegalactosyltransferaseandfattyacid2hydroxylase
AT grotheclaudia myelinationintheabsenceofudpgalactoseceramidegalactosyltransferaseandfattyacid2hydroxylase
AT gieselmannvolkmar myelinationintheabsenceofudpgalactoseceramidegalactosyltransferaseandfattyacid2hydroxylase
AT eckhardtmatthias myelinationintheabsenceofudpgalactoseceramidegalactosyltransferaseandfattyacid2hydroxylase